Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates.
He W, Ou T, Skamangas N, Bailey CC, Bronkema N, Guo Y, Yin Y, Kobzarenko V, Zhang X, Pan A, Liu X, Xu J, Zhang L, Allwardt AE, Mitra D, Quinlan B, Sanders RW, Choe H, Farzan M.
He W, et al. Among authors: skamangas n.
Immunity. 2023 Oct 10;56(10):2408-2424.e6. doi: 10.1016/j.immuni.2023.07.003. Epub 2023 Aug 1.
Immunity. 2023.
PMID: 37531955
Free PMC article.